News | News By Subject | News by Disease News By Date | Search News

Inflammatory Bowel Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Seres Therapeutics Snags Monumental $1.9 Billion IBS Deal with Nestlé Health Science     1/11/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
23andMe, Inc., Pfizer Inc. (PFE) Strike Pact To Research The Genetics Of Inflammatory Bowel Disease     8/12/2014
New Direction For Drugmakers Such As Merck & Co., Inc. (MRK), Sanofi (France) (SAN.PA): Seeking Cure For Deadly Bowel Infection     4/14/2014
Takeda's Inflammatory Bowel Drug's Risks Questioned     12/5/2013
BioLineRx Ltd. and Yissum Ltd. Sign a Licensing Agreement for the Development of a Novel Compound for the Treatment of Inflammatory Bowel Disease     11/12/2008
Gene Logic Inc. (GLGC) Says Bowel Disease Drug Shows Positive Results     7/27/2007
Nuvelo, Inc. (NUVO) Partners With Kirin Brewery Co., Ltd. (KNBWY) To Develop NU206, A Lead Compound From Its Secreted Proteins Program     4/4/2005
Rimonyx Pharmaceuticals Ltd. Completes First Private Investment Round And Licenses Lead Inflammatory Bowel Disease Drug Candidate To BioLineRx Ltd. For Continued Development     2/7/2005
Enzo Biochem (ENZ) Reports Interim Results For Clinical Trial Of Alequel, Its Investigational Treatment For Management Of Crohn's Disease     3/11/2004

News from Around the Web
Parasites May Actually Help Stomach And Bowel Diseases, New York University's Langone Medical Center Study     4/15/2016
Does Inflammatory Bowel Disease Discourage Pregnancy? University of Leeds Study     4/8/2016
Gel Eases Inflammatory Bowel Problems, Brigham and Women's Hospital Study     8/14/2015
Growing Human GI Cells May Lead To Personalized Treatments, Washington University in St. Louis Study     8/8/2014
Two Genes Linked To Inflammatory Bowel Disease, University of Cincinnati Study     4/23/2014
Red Meat 'Increases Risk of Bowel Cancer' - World Cancer Research Fund Study Suggests     5/24/2011
Scientists Discover New Drug Target for Inflammatory Bowel Disease: Cytokine (IL-23), Department of Gastroenterology at The Shanghai Tenth People's Study     4/1/2011
Genetic Links Found to Bowel Disease     2/7/2011
New Probiotic Combats Inflammatory Bowel Disease, Northwestern University Study     2/1/2011
Infants' Antibiotic Use Tied to Bowel Disease Risk, University of Manitoba Study     11/1/2010
American College of Gastroenterology: Serrated Adenomas Appear Among IBD Patients, University of Pennsylvania Study     10/22/2010
As Waist Grows, So Does Bowel Cancer Risk, University of Leeds Study     9/20/2010
Studies at University of Udine Offer Encouraging Data On Preventing Crohn's Disease Recurrence     8/6/2010
Genes May Exert Opposite Effects in Diabetes and Inflammatory Bowel Disease, Children's Hospital of Philadelphia Study     3/23/2010
Cannabis Hope for Inflammatory Bowel Disease, Lancaster University Study     12/21/2009

Press Releases
Takeda (TKPYY)'s Vedolizumab Demonstrated Robust Clinical Effectiveness And Safety In Inflammatory Bowel Disease In More Than 50 Real-World Studies     10/17/2016
New Study From Crohn's and Colitis Foundation of America Uncovers Gaps In Knowledge Regarding Nutrition In IBD     9/7/2016
Vitality Biopharma Advances Cannabosides For Treatment Of Inflammatory Bowel Disease     7/27/2016
Highland Therapeutics Announces Expansion Of Pipeline Into Inflammatory Bowel Disease     5/26/2016
Janssen Biotech Inc. (JNJ) To Present New Inflammatory Bowel Disease Data At Digestive Disease Week Meeting     5/16/2016
Seres Therapeutics Announces Collaboration With University of Pennsylvania Researchers To Support The Development Of Microbiome Therapeutics For Rare Genetic Metabolic Diseases And Inflammatory Bowel Disease     5/12/2016
Seres Therapeutics Announces Academic Collaborations To Support Development Of Microbiome Therapeutics For Inflammatory Bowel Disease     5/4/2016
Lycera Announces Progress In Immuno-Oncology Program Presented At The 2016 AACR Annual Meeting     4/19/2016
NYU Langone Medical Center Release: Worm Infection Counters Inflammatory Bowel Disease By Drastically Changing Gut Microbiome     4/14/2016
Lycera Announces Celgene Has Exercised Its Option To License Portfolio Of Ex Vivo RORgamma Agonist Compounds Under Global Strategic Collaboration     1/11/2016
Protagonist Therapeutics Initiates Phase 1 Study With Oral Peptide PTG-100     1/8/2016
Tobira Therapeutics Inc. Announces Initiation Of Program To Evaluate Cenicriviroc For The Treatment Of Primary Sclerosing Cholangitis     1/7/2016
Inception And Celgene (CELG) Enter Strategic Collaboration To Advance Novel Therapeutics For Inflammatory Bowel Disease     12/10/2015
Boehringer Ingelheim Partners With Leading Scientific Institutions In Inflammatory Bowel Disease Research     11/10/2015
Phase I Trial Of Cytori Therapeutics, Inc. (CYTX) Cell Therapy For Inflammatory Bowel Disease Published     10/22/2015

//-->